Infection after implantation of pulsatile mechanical circulatory support devices

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 6, 2010, Pages

  Holman, William L ^a   Kirklin, James K ^a   Naftel, David C ^a   Kormos, Robert L ^b   Desvign Nickens, Patricia ^c   Camacho, Margarita T ^d   Ascheim, Deborah D ^e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ASSISTED CIRCULATION; CONTROLLED STUDY; DEATH; DEVICE INFECTION; DISEASE SEVERITY; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; IMPLANTATION; INCIDENCE; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; UREA NITROGEN BLOOD LEVEL;

EID: 77952322776     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.01.014     Document Type: Article

References (22)

1. Kirklin J.K., Naftel D.C., Warner Stevenson L., Kormos R.L., Pagani F.D., Miller M.A., et al. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant 27 (2008) 1065-1072
2. US Department of Health and Human Services. Artificial Heart and Assist Devices: Directions, needs, costs, societal and ethical issues (1985), National Institutes of Health, Bethesda
3. el-Banayosy A., Arusoglu L., Kizner L., Tenderich G., Minami K., Inoue K., et al. Novacor left ventricular assist system versus HeartMate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg 119 (2000 Mar) 581-587
4. Frazier O.H., Myers T.J., Westaby S., and Gregoric I.D. Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann Surg 237 (2003) 631-637
5. Frazier O.H., Rose E.A., Oz M.C., Dembitsky W., McCarthy P., Radovancevic B., et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 122 (2001) 1186-1195
6. Rose E.A., Moskowitz A.J., Packer M., Sollano J.A., Williams D.L., Tierney A.R., et al. The REMATCH trial: rationale, design, and end points. Ann Thorac Surg 67 (1999) 723-730
7. Deng M.C., Loebe M., el-Banayosy A., Gronda E., Jansen P.G., Vigano M., et al. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation 103 (2001) 231-237
8. Frazier O.H., Rose E.A., Macmanus Q., Burton N.A., Lefrak E.A., Poirier V.L., et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg 53 (1992) 1080-1090
9. Goldstein D.J. Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation Suppl (2003) 108 II272-7
10. Portner P.M., Jansen P.G., Oyer P.E., Wheeldon D.R., and Ramasamy N. Improved outcomes with an implantable left ventricular assist system: a multicenter study. Ann Thorac Surg 71 (2001) 205-209
11. Lietz K., Long J.W., Kfoury A.G., Slaughter M.S., Silver M.A., Milano C.A., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116 (2007) 497-505
12. Long J.W., Kfoury A.G., Slaughter M.S., Silver M., Milano C.A., Rogers J., et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail 11 (2005) 133-138
13. Holman W.L., Pamboukian S.V., Bellot S.C., Blood P.S., Tallaj J.A., Sharpton J.L., et al. Use of an intraperitoneal ventricular assist device with a polytetrafluoroethylene barrier decreases infection. J Heart Lung Transplant 27 (2008) 268-271
14. Holman W.L., Rayburn B.K., McGiffin D.C., Foley B.A., Benza R.L., Bourge R.C., et al. Infection in ventricular assist devices: prevention and treatment. Ann Thorac Surg 75 suppl (2003) S48-S57
15. Rose E.A., Gelijns A.C., Moskowitz A.J., Heitjan D.F., Stevenson L.W., Dembitsky W.P., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
16. Holman W.L., Park S.J., Long J.W., Weinberg A., Gupta L., Tierney A.R., et al. Infection in permanent circulatory support: experience from the REMATCH Trial. J Heart Lung Transplant 23 (2003) 1359-1365
17. Holman W.L., Kormos R.L., Naftel D.C., Miller M.A., Pagani F.D., Blume E.D., et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant 28 (2009) 44-50
18. Pae W.E., Connell J.M., Adelowo A., Boehmer J.P., Korfer R., el-Banayosy A., et al. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant 26 (2007) 219-229
19. Miller L.W., Pagani F.D., Russell R.D., John R., Boyle A.J., Aaronson K.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357 (2007) 885-896
20. Schmid C., Tjan T.D.T., Christian E., Schmidt C., Wenzelburger F., Wilhelm M., et al. First clinical experience with the Incor left ventricular assist device. J Heart Lung Transplant 24 (2005) 1188-1194
21. Frazier O.H., Gregoric I.D., and Cohn W.E. Initial experience with non-thoracic, extraperitoneal, off-pump insertion of the Jarvik 2000 heart in patients with previous median sternotomy. J Heart Lung Transplant 25 (2006) 499-503
22. Westaby S., Katsumata T., Evans R., Pigott D., Taggart D.P., and Jarvik R.K. The Jarvik 2000 Oxford system: increasing the scope of mechanical circulatory support. J Thorac Cardiovasc Surg 114 (1997) 467-474